Woodline Partners’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.58M	Hold	200,998	–	–	0.01%	774
2025 Q4	$1.81M	Hold	200,998	–	–	0.01%	780
2025 Q3	$3.47M	Sell	200,998 -1,018,070	-84%	-$12.5M	0.02%	640
2025 Q2	$11.4M	Buy	1,219,068 +1,194,962	+4,957%	+$9.81M	0.06%	397
2025 Q1	$171K	Buy	+24,106	New	+$243K	﹤0.01%	882
2024 Q4	–	Sell	-481,752	Closed	-$9.9M	–	975
2024 Q3	$9.9M	Buy	+481,752	New	+$11.1M	0.08%	295
2023 Q1	–	Sell	-498,262	Closed	-$17.4M	–	734
2022 Q4	$17.4M	Buy	498,262 +150,991	+43%	+$7.18M	0.24%	128
2022 Q3	$19.4M	Buy	347,271 +288,610	+492%	+$17.9M	0.29%	104
2022 Q2	$3.04M	Buy	+58,661	New	+$2.98M	0.05%	328